申请人:Array BioPharma, Inc.
公开号:US20170119770A1
公开(公告)日:2017-05-04
Compounds of Formula I:
and salts thereof in which R
1
, R
2
, R
3
, R
4
, X, Y and n have the meanings given in the specification, are inhibitors of Trk kinases and are useful in the treatment of diseases which can be treated with a Trk kinase inhibitor such as pain, cancer, inflammation, neurodegenerative diseases and certain infectious diseases.